The hypothesis that rheumatoid arthritis is in part a manifestation of some peculiarity of the immunological mechanism has often been testedbut as yet inconclusively-in investigations which compared the immunological responses to antigenic stimuli in patients and controls. But the corollary of this hypothesis, that the peculiarity, if it exists, must be unequally distributed between the sexes has received very little attention. Because the incidence of rheumatoid arthritis is much greater in women than in men the sex ratio has often not been balanced in previous studies.
In the investigation reported here immunological responses following the injection of brucella vaccine were investigated but subjects were so chosen as to allow comparisons to be made not only between rheumatoid patients and controls but also between the sexes. Relatives of rheumatoid patients frequently exhibit immunological abnormalities similar to those found in patients, and therefore available first-degree relatives were included in the investigation which was evaluated on a statistical basis.
Brucella vaccine was chosen as antigen, because this organism was not likely to have been encountered previously by the majority of our subjects, and because the antibody produced in response to a primary stimulus is known to be a macroglobulin.
*A preliminary account of the findings reported here was presented to a meeting of the Heberden Society on June 17, 1967. An abstract and the discussion which followed was published in the Annals (1968) , 27, 285.
Material and Methods Selection of Subjects
Patients had classical or definite rheumatoid arthritis in accordance with the American Rheumatism Association criteria. The majority were attending the Royal Free Hospital, but some were drawn from the Departments of Physical Medicine of the Middlesex and North Middlesex Hospitals. All were seen by one of us and a detailed personal and family history was taken in each case. Hospital notes and x-ray films were reviewed and cases in whom the classification of the disease was doubtful were re-examined by two of us. Selected controls were matched to the patients for sex and for age within 5 years, except for women over 65 where matching age was within 10 years. Controls were members of staff of the Royal Free Hospital or outpatients receiving physiotherapy for non-inflammatory conditions. No person was included as a control who had chronic inflammatory disease, a history of hepatitis, or a personal or family history suggestive of rheumatoid arthritis or other connective tissue disease. The patient's firstdegree relatives were free from clinically obvious disease. All participants were Caucasian. The composition of groups and the sex and age distribution are shown in Table I .
Brucella Injection
The brucella vaccine' contained 2,000 million killed organisms of Brucella abortus and melitensis per ml. Each participant received a single subcutaneous injection of 0 5 ml. into the upper arm.
IMMUNOLOGICAL SEX DIFFERENCES
No serious side-effects were observed. Sixty showed no reaction to the vaccine, 214 experienced mild local pain and arm stiffness lasting I to 3 days accompanied by varying degrees of redness and swelling at the injection site, and 26 had mild generalized malaise for 1 to 2 days. A few had transient arthralgia. Fourteen controls complained of generalized symptoms but only six patients and six relatives were thus affected.
Two separate batches of the same vaccine had to be used because the manufacturer's expiry date on the first batch lapsed before all subjects could be injected; 192 received batch I and 108 batch II. Statistical analysis revealed no significant differences in antigenic potency between the batches.
Collection and Storage of Specimens
Venepunctures were carried out immediately before the injection and at weekly intervals thereafter on four occasions.
Blood was collected into plain polystyrene containers, apart from 2 ml. placed in a citrate bottle for erythrocyte sedimentation rate (ESR) measurements.
Sera were separated within 24 hours and stored at -20°C. A small portion of each serum was stored separately for the immunodiffusion tests alone, so that these tests would be performed with serum that had been frozen and thawed a minimal number of times.
Investigations
(1) Brucella-agglutinating antibodies (2) Brucella-blocking antibodies2 (3 Brucella-Blocking Antibodies.-Antiglobulin tests were done by the method of Wilson and Merrifield (1951) modified by Kerr, Coghlan, Payne, and Robertson (1966) .
Sheep Cell Agglutination Test (SCAT).-This was performed in MRC agglutination trays, based on the technique of Ziff, Brown, Lospalluto, Badin, and McEwen (1956) , but sera were absorbed once only with an equal volume of sheep cells,4 and the basic agglutinin titre was read after 2 hours' incubation at 37°C. Cells were sensitized to 50 per cent. of the BAT. Three standard positive sera of differing titres and a negative control were included in every batch of sera tested. To detect agglutination the cells were re-suspended by gentle stirring. Agglutination at a dilution of 1/32 was regarded as the minimum positive titre.
Slide Latex Test.-This was performed using reagent5 according to the manufacturer's instructions. Flocculation of latex by sera diluted 1/20 was considered positive.
Immunoglobulins.-As this was essentially a comparative study, no attempt was made to prepare pure sample of immunoglobulins to serve as standards for the immunodiffusion techniques, and values were related to commercially available standards (Hyland Laboratories).
Immunoglobulin M (IgM).-The modification by Claman and Merrill (1964) of the original technique of Oudin (1952) was employed. The specificity of the antiserum was checked by immunoelectrophoresis in agar. The length of the zone of precipitation was recorded at intervals over a period of several days to check the relationship between precipitation zone length and square root of the time, before deciding to read the tests after 72 hours. A series of dilutions of a serum rich in IgM was set up to check the linearity of the relationship between log concentration and length of precipitation zone. With each batch of test serum six replicates of standard sera were set up. Results were calculated by Oudin's method, obtaining the antigen equivalent of the antiserum agar by extrapolation for a series of dilutions of the standard serum. Development of precipitation zones took place at 30°C., and tests were read using an optically superimposed scale and low-power microscope.
Immunoglobulin G (IgG).-This is the only immunoglobulin which can be estimated by both chemical and immunodiffusion methods. As each of these techniques has relative advantages and disadvantages it was decided to use both. Roitt and Doniach (1958) was used.9
Throat and Nose Swabs.-Inocula were cultured overnight in brain-heart infusion broth containing 1:25,000 sodium azide and 1 :500,000 crystal violet, and subcultured on blood agar for haemolytic streptococci.
Results
Patients, relatives, and controls are referred to as groups (3), and the groups subdivided by sex as subgroups (6). All means are geometric means unless otherwise stated.
Brucella Antibodies
In the majority of subjects, antibodies to brucella showed a sharp rise one week after injection of antigen ( Fig. 1 ). Levels reached a peak at the end of 2 weeks and gradually declined thereafter, although they were still considerably elevated after 4 weeks. 23 subjects (16 female and 7 male) had brucella antibodies in the serum before immunization and in four cases pre-injection results were not available. Ten subjects had a negative, or minimal, antibody response and of these six had blocking antibodies.
No significant differences'0 in mean responses were observed between the groups, irrespective of whether all participants ( Fig. 1 B) or only subjects known to be exhibiting a primary antibody response ( Fig. IA) were included in the analysis.
On subdividing the groups according to sex (Fig. 2) , all three female subgroups had higher mean antibody titres than the three male subgroups. Thus female patients had a greater mean response than male patients, female relatives than male relatives, and female controls than male controls. For patients, this difference was statistically highly significant (P < 0-001) when 2B ) and, while the sex difference in antibody levels for relatives and for controls lacked statistical significance, the tendency for higher female levels was clearly present in each case. To avoid a possible bias due to the increased antibody response of known secondary reactors, the majority of whom were females, these and four subjects in whom pre-injection titres were not available were excluded from the analysis, but the exclusion of these individuals did not appreciably alter the statistical significance of the sex differences among patients (P = 0 * 002) ( Fig significantly higher female titres than male over the test period (P < 0-001), and females also had significantly raised levels (P < 0-05) 1, 2, and 3 weeks after antigen injection. Figs 3B and 3C show that this difference was maintained when subjects were subdivided according to the batch of vaccine with which they were immunized (see Fig. 3 , overleaf).
Sheep Cell Agglutination Test
Before injection of the antigen, 82 (79 per cent.) patients had a SCAT of 1/32 or over, all controls were negative, and only one relative (1 per cent.) showed a positive result (Table II, As expected, patients had very significantly higher sheep cell titres than non-patients (P < 0 001) and relatives had significantly higher titres than controls $AI1 five weeks.
(P < 0 01) when readings over the test period were combined.
After brucella injection all subgroups showed a rise in sheep cell titre. Patients of both sexes and female relatives exhibited a very significant linear increase in titre (P < 0 001) over 4 weeks. Male non-patients showed a lesser rise (but still P < 0 001); this was not linear in male relatives and although linear in male controls it was less significant (P < 0 05).
Considering all non-patients, instead of relatives and controls separately, linear regression lines were I-ut fitted to both male and female data and a c made between their slopes (Fig. 4) . BotI females exhibited a very significant inc O00l), but the rise in SCAT titre for f patients was greater than for male, the being significant at the level P = 0 * 05; tI difference between the increases shown b female patients.
comparison male controls but this difference just lacked statistih males and cal significance. :rease (P < The difference between patients and non-patients emale non-was mainly due to the significant differences in levels D difference between female patients and non-patients (P < 0 01 here was no for female patients and relatives and P < 000l for oy male and female patients and controls). Male patients' mean IgM levels, although slightly higher, did not differ significantly from those of male non-patients.
(0 112) Comparisons of mean levels in male relatives with those in male controls, and in female relatives with female controls,-showed no significant differences.
-2 25 -* -P-0.05
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Latex Test
The number of latex positive and negative subjects and of convertors from negative to positive is shown in Table II Mean IgM levels for all patients were very significantly higher than for all non-patients (P < 0 001) and there were no differences in values between relatives and controls (Fig. 5, overleaf) . Female patients' mean IgM levels were significantly higher than those of male patients (P <0 -001) and of female relatives than of male relatives (P=0 -05). IgM values for female controls were higher than for Immunoglobulin G (a) Modified Rivanol Method.-Levels determined in five weekly samples of 126 individuals (45 patients, 40 relatives, and 41 controls) showed no significant variations in levels in individuals with time. Estimations of the levels in the sera of the remaining 171 subjects were therefore restricted to two samples, the first and the fourth.
Patients had significantly higher values than controls or relatives (P <0 -001) (Fig. 6A, overleaf) , and there was no significant difference between the controls and relatives, but female relatives had higher levels than female controls (P < 0-01). The only sex difference observed was the significantly increased level (P < 0 01) in male controls compared with female controls.
(b) Immunodiffusion Method.-The second and fifth samples of 176 subjects were tested. Results were broadly comparable with those obtained by the modified rivanol method, but several of the differences found to be significant with (a) lacked significance with (b) (Fig. 6B) because of the inaccuracy of the latter method. Although patients had higher levels than non-patients, this difference was significant for the women patients only (P < 0 001), and the sex difference found by the rivanol method in the controls was not significant by the immunodiffusion method. 
Immunoglobulin A
The first and fourth samples of each of 180 subjects were tested. The mean level of IgA in patients was significantly greater than in nonpatients (P < 0 001), taking all subjects together or the sexes separately (Fig. 7, opposite) . Male and female controls showed a higher mean level than relatives, but the difference was significant only in the case of the man (P <0 -01). There were no significant differences between the sexes in any of the groups, and levels in individuals appeared to be stable with time.
Antinuclear Factor
All five samples of 163 subjects were tested and the third sample alone of the remaining subjects. No changes in mean titre were detected after brucella injection and titres in individuals were stable. 37 patients (36 per cent.) and three relatives (3 per cent) had a positive ANF; there were no positive controls (Table III) .
22 female patients (42 per cent.) but only fifteen male patients (29 per cent.) were positive. Two female relatives (4 per cent.) and one male (3 per cent.) were positive. Although more females than males had antinuclear antibodies, this difference between the sexes was not significant.
Morphologically, the majority of positive tests were homogenous, but two had a speckled and two a peripheral pattern.
Erythrocyte Sedimentation Rate
This was determined in 202 subjects (70 patients, 59 relatives, and 73 controls). The mean (arithmetic mean) initial rate was 30 mm./lst hr. for patients, 8 5 for relatives, and 6-4 for controls. Patients had significantly higher mean values than nonpatients (P < 0 001) and there was no difference between relatives and controls.
There was no rise in the mean rate one week after brucella injection in patients but relatives and controls showed a significant rise (P < 0 001) (Table IV) . Mean rates for female patients were higher than for male patients, but owing to the great variability of the ESR in patients, the sex difference was not significant. Among non-patients females had significantly higher rates than males (P < 0 01), and this reflects the known elevation of ESR in females, but female non-patients also showed a greater rise in ESR one week after antigen injection (P < 0-001) than male non-patients in whom the rise was much less significant (P < 0 05).
Antistreptolysin-O Antibodies ASO titres showed no significant change with time. No differences were found in the proportions of patients and non-patients, or of men and women, having high and low ASO titres (>150 and < 150 units).
Thyroid Antibodies
These were tested in 95 cases (33 patients, 38 relatives, and 24 controls) on five blood samples. The TRC was positive (greater than 1/250) in two (6 per cent.) patients, one of whom was known to have thyroid disease, one (3 per cent.) relative, and one (4 per cent.) control. The complement-fixation test was positive in one relative only. These tests were discontinued for the remaining subjects because the incidence of positive tests was no greater than could be expected in the general population.
Streptococci
Haemolytic streptococci belonging to Lancefield Groups A, C, or G were not isolated from any nose or throat swabs.
Venereal Disease
Serological tests for syphilis were negative in all subjects.
Discussion
Our findings suggest the presence of fundamental immunological differences between men and women mainly concerning the macroglobulin system. We observed no differences in antibody response to brucella between rheumatoid patients, their relatives, and controls, and this is in agreement with the findings of Shearn, Epstein, and Engleman (1963) and of Waller, Ellman, and Toone (1966) , and with results of others, who used different antigens (Larson and Tomlinson, 1951; Creger, Choy, and Rantz, 1951; Barr, Buchanan, Doniach, and Roitt, 1964) . Conflicting findings of heightened antibody response in rheumatoid patients were reported by Greenwood and Barr (1960) , Meiselas, Zingale, Lee, Richman, and Siegel (1961) , and Houba, Adam, Malecek, and Tesarek (1964) . The sex distribution was not published in the above investigations, except by Barr and others (1964) , who used patient groups which were predominantly, and control groups which were entirely, female, and by Meiselas and others (1961) , who compared female patients with male controls. These authors interpreted the increased immunological response of patients over controls as evidence of hyperreactivity, whereas their observations may have reflected differences in reactivity between men and women.
Our findings confirm the results of recent studies of normal populations which reveal higher IgM levels in women in the United States (Lichtman, Vaughan, and Hames, 1967; Butterworth, McClellan, and Allansmith, 1967) and in Denmark (Jensen, 1967) . Studies which show that American Negroes have higher immunoglobulin levels than Caucasians (Pollak, Mandema, Doig, Moore, and Kark, 1961; Fudenberg, 1963) , Tibetans than Swiss (Hartmann and Ritzel, 1967) , and African Negroes domiciled in England than Caucasians (Cohen, McGregor, and Carrington, 1961) provide further evidence that immunoglobulin levels are under genetic control.
In this study a heightened sensitivity of the normal female immune system compared with that of the male is also revealed, after brucella vaccine injection, by a higher specific antibody response and a greater anamnestic response. Evidence for the latter lies in the significantly greater rise in SCAT titres, and the increased immunological reactivity is reflected in a steeper rise in the ESR. It has been shown that the immediate antibody to brucella is usually an IgM (Reddin, Anderson, Jenness, and Spink, 1965; Kerr, Payne, Robertson, and Coombs, 1967) ; further studies will reveal whether this greater response in females is induced by other antigens.
The idea of a hyperreactive host response in females receives support from experimental work on animals concerned with homograft rejection (Brent and Medawar, 1966) , with host susceptibility to bacteria (Wheater and Hurst, 1961) , tumour cells (Gorer and Kaliss, 1959; Batchelor and Chapman, 1965) , and foreign proteins (Dresser, 1962) , and with immune depression after neonatal thymectomy (Balner and Dersjant, 1966) .
If antibodies were produced only after antigenic stimulation, one might expect that a hyperreactive diathesis in females would not become manifest until after antigenic challenge, in late infancy and particularly during school years. In this context, it is worthy of note that Butterworth and others (1967) reported significantly higher IgM levels in girls over the age of 7 compared with boys, while others observed no such differences in early infancy (Stiehm and Fudenberg, 1966) . Support for a more sensitive host response in females also comes from reports which indicate that the mortality rates of female infants from infections are significantly lower than those of male infants. Immunological deficiency diseases such as congenital agammaglobulinanaemia are commoner in male infants (Janeway, 1966a, b) , suggesting greater vulnerability of the male immune system. We found no significant individual variation in serum concentrations of immunoglobulins G, A, or M during the time of the study, and it appears that these immunoglobulins are normally stable for each individual . We cannot explain the higher levels of IgG in male than in female controls (P < 0 -01), and more work is necessary to confirm these results.
Sex hormones, corticosteroid therapy, and chronic infection may alter immune responses. Chronic infection was ruled out in our controls by strict selection and the relatives were also free from clinically obvious disease. The effect of sex hormones is known from animal experiments wherein oestrogens tend to stimulate the reticuloendothelial system while testosterone may depress immunological activity (von Haam and Rosenfeld, 1942; Sherman, Adner, and Dameshek, 1963) . As 49 per cent. of our female participants were over the age of 50 it appeared improbable that oestrogens would have caused the higher level of circulating antibodies in women than in men, but it was thought possible that male hormones may have depressed antibody production in the men. However, the younger subjects (up to 50 years of age) of each sex produced significantly more antibodies than the older members of the same sex, and this difference was much less significant for the women (P < 0 -05) than for the Ig M men (P < 0 001) (Fig. 8) . Considering these results, it is unlikely that the differences in antibody levels were sex hormone dependent.
Corticosteroids are known to depress the reticuloendothelial system. However, the mean primary response antibrucella antibody levels of eight males and four females on steroid therapy proved not to be significantly different from the antibody levels of the remaining patients of corresponding sex.
The above considerations are also relevant to IgM levels. Fig. 8 shows significantly higher mean IgM levels in younger, compared with older, normal women (P < 0 001). This, in the light of the experimental work mentioned, would suggest oestrone-dependent increase of IgM production, particularly as no change with age is present in normal men. However, the issue is not clear-cut, as male, but not female, rheumatoid patients show a significant age difference in IgM levels, values being higher in younger male patients compared with those over 51 years of age (P < 0 025), but there is no difference in mean levels between younger and older female patients.
Reports of immunoglobulin levels in rheumatoid arthritis are variable (Barden, Mullinax, and Waller, 1967; Bakker, Imhof, Mul, and Ballieux, 1967) ; Wasastjerna, Vilppula, and Jeglinsky, 1967; Claman and Merrill, 1966) and the possibility of sex differences was not explored in these studies. In this investigation, immunoglobulins G, A, and M were significantly increased in all patients compared with controls or relatives, but differences in levels between the sexes were present with IgM Age (years) 1.50 only (P < 0 001), female patients having higher values than male patients. Rheumatoid men did not have significantly higher values than nonrheumatoid men, and the high P value obtained for the IgM difference between patients and controls (P < 0-001) was due mainly to higher values in women patients. Female patients also had a higher incidence (not statistically significant) of antinuclear antibodies (42 per cent.) compared with male patients (29 per cent.). Other workers have observed an increased incidence of antinuclear antibodies in women (Seligmann, Cannat, and Hamard, 1965; Svec and Veit, 1967) . Under experimental conditions female animals likewise seem to exhibit autoimmune phenomena more readily than male animals (Pearson, 1959; Bielschowsky, Helyer, and Howie, 1959; Helyer and Howie, 1961; Holborow and Denman, 1967) .
In our subjects the incidence of rheumatoid factor was equal for the sexes. This is in agreement with findings of Ball and Lawrence (1961) in multiple population samples involving several European countries, and of Litwin and Singer (1965) in aged people in New York. There is little doubt that the small, but statistically highly significant, rise in mean sheep cell titres (P < 0 001) in all groups was due to brucella vaccine injections. A slight increase in sensitized sheep cell agglutinins associated with antigenic stimulation can be expected, as conversion to sero-positivity has been reported in diverse infective conditions (Bonomo, Gillardi, and Tursi, 1966; Williams and Kunkel, 1962; Singer, Plotz, Peralta, and Lyons, 1962; Mustakallio, Lassus, and Wager, 1967) . The failure of Waller and others (1966) to detect changes in rheumatoid factor titres after brucella injection may have been due to their small sample size. In patients, we did not detect the same sex differences in SCAT rise as were present in non-patients (Fig. 4) , but this may have been due to the much greater variation of titres encountered among patients.
The question arises whether immunoglobulin M levels in rheumatoid women are increased as a result of the disease or whether previously elevated levels are related to the greater female incidence of autoimmune disease. Negroid races, in whom immunoglobulin G levels are high, apparently as a result of hereditary influence, also have a much increased incidence of such connective tissue diseases as sarcoid (Hunt, 1966) and systemic lupus erythematosus (Siegel and Seelenfreund, 1965) . The ability of normal females, intensified in females with rheumatoid arthritis, to effect higher levels and more rapid mobilization of antibodies than males raises the question of an aetiological link between this hyperreactivity and the female predisposition to rheumatoid disease. Might a more sensitive immune system perhaps have conferred phylogenetic advantages on the female, these advantages, however, tending to be offset by an increased susceptibility to connective tissue disease? But were a heightened immune response an invariably necessary predisposing factor it might be expected that the disease would be found among that section of males having such a heightened response, and the sex differences would then be less in patients than in normal persons. Inasmuch as the differences that are present between the sexes in normal individuals are retained and even intensified in patients with rheumatoid arthritis, it is clear that the relationship between the sex differences and the sex incidence of the disease is a complex one.
Summary Antibody responses to brucella vaccine were studied in 300 individuals, of whom 103 had rheumatoid arthritis, 91 were healthy relatives ofthe patients, and 106 were matched controls. The proportions of male and female subjects were almost equal.
Female patients, relatives, and controls all produced higher mean levels of specific antibody to brucella than the corresponding males, and the sex difference in antibody response was statistically highly significant. No differences in antibody production were observed between patients, relatives, and controls.
After an injection of brucella vaccine, sheep cell agglutination tests for rheumatoid factor showed significant increases in mean titres in all groups. Patients of both sexes and female relatives and controls had a more significant increase than male relatives and controls, and this difference between male and female non-patients was statistically significant.
Mean levels of immunoglobulin M were significantly higher in all female subjects compared with males, and female patients had the highest levels. Serum concentrations were significantly higher in female patients than in female non-patients, but in males values did not differ significantly in patients and non-patients. No Table V are V/8 51/4 x number in sub-group; the standard errors of the weekly sub-group means for testing changes from week to week are aV0 646/number in sub-group. Since there were different proportions of men and women in the three groups a correction for disproportion was made in the analysis (Snedecor, 1956 ).
SCAT.-The figures used were log2 T, where T is the last titre to show agglutination. Since patients as a group have very much higher titres than nonpatients, and correspondingly big variances, they were analysed separately from non-patients. Straight lines could be fitted to the weekly means for each sub-group. In the analysis that part of the "between weeks" sum of squares ascribable to linear regression is shown. As an example the analysis of the figures for women non-patients is given (Table VII) . Diferencias inmunologicas entre los sexos. Un estudio de pacientes con poliartritis reumatoide, sus parientes y testigos SUMARIO Las reacciones de anticuerpos a la vacuna brucella fueron estudiadas en 300 individuos, de los cuales 103 padecian poliartritis reumatoide, 91 eran parientes saludables de los pacientes, y 106 testigos iguales. Las proporciones de sujetos masculinos y femeninos eran casi iguales. Los pacientes, familiares y testigos femeninos produjeron niveles mas altos de anticuerpos especificos contra la brucella, que los correspondientes masculinos, y la diferencia de sexo en la reacci6n de anticuerpos fue, estadisticamente, muy significativa. No se observ6 ninguna diferencia en la produccion de anticuerpos entre pacientes, parientes y testigos.
Despues de una inyecci6n de vacuna brucella, las pruebas de aglutinaci6n de celula de oveja en busca de factores reumatoides mostraron aumentos significativos en las concentraciones promedio en todos los grupos. Los pacientes de ambos sexos y los parientes y testigos femeninos tuvieron un aumento mas significativo que los parientes y testigos masculinos, y esta diferencia entre hombres y mujeres no pacientes fue estadisticamente significativa.
